Expression of inducible nitric oxide synthase in failing and non-failing human heart

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 1, 1996, Pages 165-169

  Thoenes, Martin ^a   Förstermann, Ulrich ^b   Tracey, W Ross ^c   Bleese, Niels M ^d   Nüssler, Andreas K ^e   Scholz, Hasso ^a   Stein, Birgitt ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c ABBOTT LABORATORIES   (United States)

^d ALBERTINEN KRANKENHAUS   (Germany)

^e UNIVERSITY OF ULM   (Germany)

Author keywords

cGMP; Heart failure; iNOS protein; Nitric oxide; Sepsis

Indexed keywords

CYCLIC GMP; MITOXANTRONE; NITRIC OXIDE SYNTHASE;

ARTICLE; BECKER MUSCULAR DYSTROPHY; CARDIOTOXICITY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ENZYME ACTIVITY; HEART FAILURE; HEART LEFT VENTRICLE MUSCLE; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; ISCHEMIC HEART DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SEPTIC SHOCK;

EID: 0343337644     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0016     Document Type: Article

References (10)

1. BALLIGAND JL, UNGUREANU-LONGROIS D, SIMMONS WW, PIMENTAL D, MALINSKI TA, KAPTURCZAK M, TAHA Z, LOWENSTEIN CJ, DAVIDOFF AJ, KELLY RA, SMITH TW, MICHEL T, 1994. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J Biol Chem 269: 27580-27588.
2. DE BELDER AJ, RADOMSKI MW, WHY HJF, RICHARDSON PJ, BUCKNALL CA, SALAS E, MARTIN JF, MONCADA S, 1993. Nitric oxide synthase activities in human myocardium. Lancet 341: 84-85.
3. DE GROOTE MA, MARTIN MA, DENSEN P, PFALLER MA, WENZEL RP, 1989. Plasma tumor necrosis factor levels in patients with presumed sepsis. JAMA 262: 249-251.
4. EVANS T, CARPENTER A, COHEN J, 1994. Inducible nitric-oxide-synthase mRNA is transiently expressed and destroyed by a cycloheximide-sensitive process. Eur J Biochem 219: 563-569.
5. LAEMMLI UK, 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
6. i-proteins in heart failure. Lancet October 22, 936-937.
7. ++-dependent constitutive nitric oxide synthase is not involved in the cyclic GMP-increasing effects of carbachol in ventricular cardiomyocytes. J Pharmacol Exp Ther 266: 919-925.
8. STEIN B, FRANK P, SCHMITZ W, SCHOLZ H, 1995. Long-term treatment of cardiomyocytes with endotoxins and cytokines induces negative inotropic effects mediated by nitric oxide. In: S. Moucada, M. Teelisch, R. Bude, E. A. Higgs (eds.) The Biology of Nitric Oxide, Physiology and Clinical Aspects, Portland Press Proceedings Vol. 3, 85-89.
9. TRACEY WR, XUE CH, KLINGHOFER V, BARLOW J, POLLOCK JS, FÖRSTERMANN U, JOHNS RA, 1994. Immunochemical detection of inducible NO synthase in human lung. Am J Physiol 266: L722-L727.
10. WINLAW DS, SMYTHE GA, KEOGH AM, SCHYVENS CG, SPRATT PM, MACDONALD PS, 1994. Increased nitric oxide production in heart failure. Lancet 344: 373-374.